TITLE

Brain Isoprenoids Farnesyl Pyrophosphate and Geranylgeranyl Pyrophosphate are Increased in Aged Mice

AUTHOR(S)
Hooff, Gero; Wood, W.; Kim, Ji-Hyun; Igbavboa, Urule; Ong, Wei-Yi; Muller, Walter; Eckert, Gunter
PUB. DATE
August 2012
SOURCE
Molecular Neurobiology;Aug2012, Vol. 46 Issue 1, p179
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
80028217

 

Related Articles

  • Importance of geranylgeranyl pyrophosphate for mesangial cell DNA synthesis. Massy, Ziad A.; Guijardo, Carlos; Oda, Hiroaki; Kasiske, Bertram L.; Keane, William F.; O'Donnell, Michael P. // Kidney International Supplement;Jul1999, Issue 71, pS-80 

    Examines the importance of geranylgeranyl pyrophosphate, an isoprenoid product, for mesangial cell DNA synthesis. Dependence of platelet-derived growth factor-stimulating mesangial cell DNA synthesis on Farnesyl pyrophosphate and geranylgeranyl pyrophosphate; Measurement of the total cell...

  • Increased Expression of RhoA in Epithelium and Smooth Muscle of Obese Mouse Models: Implications for Isoprenoid Control of Airway Smooth Muscle and Fibroblasts. Ross, Kristie R.; Darrah, Rebecca J.; Hodges, Craig A.; Lang, LaTresa; Kelley, Thomas J. // Journal of Allergy;2013, p1 

    The simultaneous rise in the prevalence of asthma and obesity has prompted epidemiologic studies that establish obesity as a risk factor for asthma. The alterations in cell signaling that explain this link are not well understood and warrant investigation so that therapies that target this...

  • Pitavastatin Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells. Morofuji, Yoichi; Nakagawa, Shinsuke; So, Gohei; Hiu, Takeshi; Horai, Shoji; Hayashi, Kentaro; Tanaka, Kunihiko; Suyama, Kazuhiko; Deli, Maria A.; Nagata, Izumi; Niwa, Masami // Cellular & Molecular Neurobiology;Jul2010, Vol. 30 Issue 5, p727 

    Statins have a neuroprotective effect in neurological diseases, a pleiotropic effect possibly related to blood–brain barrier (BBB) function. We investigated the effect of pitavastatin on barrier functions of an in vitro BBB model with primary cultures of rat brain capillary endothelial...

  • Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats. Yang, Jian; Chen, Yu-Ning; Xu, Zao-Xian; Mou, Yun; Zheng, Liang-Rong // Cellular Physiology & Biochemistry (Karger AG);Jul2016, Vol. 39 Issue 1, p229 

    Background: In our previous study, farnesyl pyrophosphate synthase (FPPS) was shown to be increased in spontaneously hypertensive rats (SHR) and in mice with angiotensin-II induced cardiac hypertrophy. Overexpression of FPPS induced cardiac hypertrophy and fibrosis in mice, accompanied by an...

  • Isoprenylated proteins. McTaggart, S. J. // Cellular & Molecular Life Sciences;Feb2006, Vol. 63 Issue 3, p255 

    Isoprenoids are synthesized in all living organisms and are incorporated into diverse classes of end-products that participate in a multitude of cellular processes relating to cell growth, differentiation, cytoskeletal function and vesicle trafficking. In humans, the non-sterol isoprenoids,...

  • The analytical determination of isoprenoid intermediates from the mevalonate pathway. Nürenberg, Gudrun; Volmer, Dietrich // Analytical & Bioanalytical Chemistry;Feb2012, Vol. 402 Issue 2, p671 

    In this article, assays on the analytical determination of farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), two important isoprenoid intermediates at biochemically relevant branching points in the mevalonate pathway, are summarized and reviewed. There is considerable recent...

  • The analytical determination of isoprenoid intermediates from the mevalonate pathway. Nürenberg, Gudrun; Volmer, Dietrich A. // Analytical & Bioanalytical Chemistry;Jan2012, Vol. 401 Issue 9, p671 

    In this article, assays on the analytical determination of farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), two important isoprenoid intermediates at biochemically relevant branching points in the mevalonate pathway, are summarized and reviewed. There is considerable recent...

  • Statin Therapy for Native and Peri-Interventional Coronary Heart Disease. Smith, D. A.; Galin, I. // Current Molecular Medicine;Aug2006, Vol. 6 Issue 5, p589 

    Atherosclerosis is a slow, complex process involving many different cell types and their interactions producing excessive oxidant stress, increased inflammation, abnormal endotheliumdependent vasodilation, and localized increases in thrombogenic and decreases in fibrinolytic factors. Numerous...

  • Cholesterol-independent Effects of Statins in Inflammation, Immunomodulation and Atherosclerosis. Arnaud, Claire; Veillard, Niels S.; François, Mach // Current Drug Targets - Cardiovascular & Haematological Disorders;Apr2005, Vol. 5 Issue 2, p127 

    Atherosclerosis and its complications still represent the major cause of death in developed countries. Statins have revolutionized the treatment of dyslipidemia and demonstrated their ability to reduce and prevent coronary morbidity and mortality. Statins inhibit 3-hydroxyl-3-methylglutaryl...

  • Pleiotropic effects of statins. Kavalipati, Narasaraju; Shah, Jay; Ramakrishan, Ananthraman; Vasnawala, Hardik // Indian Journal of Endocrinology & Metabolism;Sep/Oct2015, Vol. 19 Issue 5, p554 

    Statins or 3-hydroxy-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors not only prevents the synthesis of cholesterol biosynthesis but also inhibits the synthesis of essential isoprenoid intermediates such as farnesyl pyrophosphate, geranylgeranyl pyrophosphate, isopentanyl adenosine,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics